Preemptive Pregabalin in Myringoplasty
WithdrawnNot applicableNCT03603626
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of this study was to investigate the effect of preemptive pregabalin on post-operative pain reduction after myringoplasty.
Study details
- Official title
- Effect of Preemptive Pregabalin for Post-operative Pain Relief in Myringoplasty
- Conditions
- Post-operative Analgesia
- CSOM - Chronic Suppurative Otitis Media
- Interventions
- Drug: Pregabalin 150mg
- Drug: Placebo oral capsule
- Sponsor
- Dhulikhel Hospital
- Collaborators
- Kathmandu University School of Medical Sciences
- Start date
- 2015-09
- Primary completion
- 2017-12
- Sex
- All
- Age range
- from 18 Years to 60 Years
- Results posted
- No results posted in this snapshot
- Countries
- Nepal
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Cases of Chronic suppurative otitis media (CSOM) inactive planned for endoscopic myringoplasty under local anesthesia, * Age \>= 18 years * either sex. Exclusion Criteria: * Revision cases, * Pregnancy or breastfeeding, * Known or suspected sensitivity or contraindication to pregabalin, * Patient using medication for chronic pain, * History of seizure disorder, * Mental retardation.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03603626